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Chromatin immunoprecipitation (ChIP)1 has become a
popular method in regulatory biology for studying the
binding of transcription factors to genomic loci. The ChIP
technique has been traditionally used for the demonstra-
tion of the in vivo binding of a given transcription factor to
the genomic regions of interest [1,2]. In recent years, this
technique has also become a useful genomic tool for identi-
fying unknown target loci of transcription factors by clon-
ing and analyzing the retrieved DNA fragments that have
been bound by the transcription factors [3–5]. Despite the
increasing popularity of the latter approach, this ChIP-
based cloning approach is still problematic mainly due to
the low eYciency of cross-linking and subsequent cloning
steps in existing protocols. Here, we describe a simple mod-
iWcation that can dramatically increase the eYciency of
existing ChIP-based cloning methods.
Most available ChIP protocols employ a similar overall
strategy to retrieve a pool of protein-bound DNAs (Fig. 1).
In brief, chromatin is cross-linked by formaldehyde (Step
1), fractionated by sonication (Step 2), and puriWed by the
antibody raised against a given protein (Step 3), and later
the bound DNAs are reverse cross-linked by heat treatment
and puriWed from chromatins by proteinase K treatment
and phenol/chloroform extraction (Step 5). Since the initial
chromatin for ChIP is sheared with sonication, both ends
of the puriWed DNAs are usually modiWed further by Wll-in
reactions to generate blunt-end DNA fragments (Step 6).
This modiWed pool of genomic DNAs usually becomes
starting DNA material for constructing clone libraries for
the identiWcation of unknown target regions for a given
DNA-binding protein (Step 7). However, the DNA
amounts retrieved from the ChIP and following modiWca-
tions tend to be very small and DNA fragments with blunt
ends need to go through ineYcient blunt-end ligation reac-
tions for cloning. The combination of these two ineYcient
steps has been a major bottleneck for constructing genomic
libraries with reasonable clone representation. To circum-
vent this problem, most existing protocols utilize the PCR
ampliWcation (Step 6) for the following cloning step [6],
which could easily change the initial representation of the
DNA pool and contaminate with unwanted artifact DNAs.
We reasoned that the ineYcient Wll-in and blunt-end liga-
tion reaction (Step 6) could be avoided by the digestion of
the antibody-bound chromatin using 4-bp cutters of restric-
tion enzymes before the elution (Step 4). Restriction
enzyme digestion of the chromatin that has been immobi-
lized to protein A agarose beads would shorten further the
lengths of relevant DNA fragments for the identiWcation of
potential binding motifs for a given protein (or transcrip-
tion factor). The inserts with shorter lengths should make
the later-stage sequence inspection more eYcient and
straightforward.
To test the feasibility of this approach, we performed
three trials of ChIP cloning experiments using polyclonal
antibodies against mouse DNA-binding proteins, YY1,
Suz12, and Peg3 (paternally expressed gene 3). The perfor-
mance of this approach was compared with the results from
parallel ChIP cloning experiments using the traditional
approach [4,5]. We prepared chromatin using neonatal
mouse brains with the following method. One gram of 10-
day-old mouse brain tissues was homogenized in 10 ml PBS
buVer containing protease cocktail, cross-linked with 1%
formaldehyde for 20 min at 37 °C, washed twice with 10 ml
of PBS by centrifugation at 2000 rpm for 10 min to remove
cell debris, lysed with 5 ml of the SDS lysis buVer (http://
www.upstate.com/img/coa/17-295-32348.pdf) in 10 min on
ice, and sonicated with seven strokes of 10-s pulse at the
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30% output of the maximum strength in SoniWer W-350
(Branson Sonic Power Co.). The 5 ml sonicated lysate was
aliquoted into 10 fractions of 0.5 ml and stored at an
¡80 °C freezer. Each ChIP cloning trial used one fraction
of these lysates. We followed the ChIP protocol developed
by a commercial Wrm (Upstate Biotechnology Inc., NY)
with minimum modiWcations. In brief, the 0.5 ml lysate was
combined with 4.5 ml of the ChIP dilution buVer and incu-
bated with preimmune serum overnight, and the preim-
mune serum was removed on the following day with 0.1 ml
of protein A agarose beads. This precleared chromatin was
incubated again with 4 g of a given antibody at 4 °C over-
night. The chromatin was puriWed using 0.1 ml of protein A
agarose beads after sequential washing with 2 ml of each of
the following four buVers: LiCl, high salt, low salt immune
complex wash, and TE buVer. For the traditional ChIP
cloning approach, we eluted the chromatins by incubating
the chromatins in 0.5 ml of the elution buVer (0.1 M
NaHCO3 and 1% SDS) for 30 min at room temperature.
The eluted chromatin was reverse cross-linked by adding
20 l of 5.0 M NaCl and subsequently incubated at 65 °C
overnight. We treated reverse cross-linked chromatin with
proteinase K (AMRESCO Inc., OH) for 1 h at 45 °C and
extracted DNAs with phenol/chloroform solution. The iso-
lated DNAs were treated with Wll-in reactions using Kle-
now fragments (New England Biolabs, MA). The modiWed
DNAs were cloned into the EcoRV-digested pZErO-2 vec-
tor or the blunt end TOPO vector (Invitrogen, CA). For the
modiWed approach, we performed restriction enzyme diges-
tion right after the Wnal washing of chromatins with TE
(Step 4) by adding 40 units of Sau3AI into chromatin
Fig. 2. Comparison of two diVerent cloning approaches for ChIP-derived DNAs. Summary of the total clone number and size distribution of inserts for
each ChIP library that has been generated through (A) the traditional and (B) the modiWed approaches. The total clone number for each library is shown
at the bottom. The insert size distribution of each library is presented in a 100-bp increment scale on the x axis with the y axis representing the percentiles
of each category of insert size. (C) A subset of sequences (n D 21) derived from the YY1-ChIP library is shown with the potential YY1-binding motif
underlined. Two core motifs (ACAT and CCAT) with adjacent nucleotides aVecting YY1 binding represent the consensus sequence of YY1 binding sites
(CGC/ACATnTT; n means any base) [7].
 Sequences of YY1-ChIP clones
>YY1_32     GATCATTCGCCATCCTGGGAACTCACCTGAAATGCAGATC
>YY1_154    GATCCTCAGAGTCACATAATTTAGGGAGCCT CCATTGTCTCCAGATC
>YY1_129    GATCCCAAACACATATTTAAGGTAGTATGATACTCAGGTTGTAGTTTGATC
>YY1_125    GATCTTCACAGGACTCCTCTCTGGTCTTCTGTTGTTCCCTGT GCCATGATGATC
>YY1_128    GATCTTAAATAATACTACATTGCCTAATCTTCTCTTTTGTTTTTCGGCTGAGATC
>YY1_126    GATCCCTTTAGCTCCTTGGGTACTTTCTCTAGCTCCT CCATTGGGAGCCTGTGATC
>YY1_159    GATCCATCGGCCCATACGAACAGCGTATCTTCATTGATTCCCTTGGCGCCAATCCAAATCTGATC
>YY1_51     GATCAACGGCAGAGGTCCCAGCTCCTTGTGGCTGCT GCCATCCCTCCATGACCTCTACATCAGCTCCTGCCTCCAGGATC
>YY1_29     GATCAAGCGTATGCAGCCGCCGCATTGCATCA GCCATGATGGATACTTTCTCGGCAGGAGCAAGGTGAGATGACAGGAGATC
>YY1_135    GATCAACGAAAATAATTATGCCTGTTTCAAGCTTTTGTTCATTAGGGAGAGGGATAAA CCATAAACAAAATCACTATATCACCAGATC
>YY1_54     GATCAAACCTAGGGTTTGAGTCTGGACTTTGCTTCTGTAGCTTCT ACATCTGAATGTTGTCCTGTGATTGACATGAGTCTTTCTTTGTGATC
>YY1_153    GGATCTTCCCTCCCTCTCTTCTAAGCCCACCCACTTCCACTC CCATTACCTTTACTACAGATATGAACCGAGTCACAGATTACTGTCATGATC
>YY1_66     GCTCTGGATCTTTCCTGGTTCCTAGGTAGGAATTTCCAACCCTCTGGCCCTGT TGACATATCCAGACACTTCAAAACCAAGCTTTCCTTCTTGATC
>YY1_1      GATCTGTGTAGGTCCTGTGCTTGCTGCTTTAGGGAGAGCC ACATCCTGATGGTCCTGGTCCTGGTCCTGGTCCCGGTCCCGGTCCCGGTCCCGATC
>YY1_45     GATCTGATTTAACTTTGGTACCTGATATCTGTCCAGAAATTTGT CCATTTCATCCAGGTTTTCCAGTTTTGTTGAGTATAGCCTTTTGTAG AAGGATC
>YY1_65     GATCAACAACTCTACATCTAATAAGCTGATATACAAAATATGTAAAGTACTCAAGAAACTAGACATCAACAAACCAAATAACTCAATTAAAAATGGTGTACAGATC
>YY1_80     GATCTAGAATGAGACGGCATGATTTCGCTCAGTTAACA CCATTTACAGCCGCGAGTAATGAGTACGGTGAATTTTGGTGCAGGAACTTCACGCTGCCGATTATGGATC
>YY1_22     GATCTCCTTGTATCCTTGTTGAAGTCAGTTTTATAAGTAGAGTTTTGAATTCTTTGTCGTTTCAT CCATTTCATGATTTTTTTTTTAATATGGCATAGAATTCAGGATC
>YY1_175    GATCACACATGCATCTCATAAGTTCTACCTGGCAACCGACCACTCCTGGCAGATA CCATACTCATTTCCTTCAGCAAATCTGAGGAAAGCAGGAAACACTGGCTCCGGATC
>YY1_89     GATCAAATTATGAAACCTCCCTGCATCTGACCTGCTGCCTCTCATCTGTCACTTCACTGGGGACACAACAGACCT ACATCCCTCTTTGTCTGCCATTCTAGAAAAAATAGGATC































































Fig. 1. Schematic diagram of a modiWed cloning strategy for ChIP-derived
DNAs. The traditional approach requires Wll-in and blunt-end ligation step
for cloning (Steps 1–3, 5–7), whereas the modiWed approach (shown on the
left) adds one restriction enzyme digestion step before the elution step and
subsequently skips the Wll-in and blunt-end ligation step (Steps 1–5, 7).
1. Cross-link chromatin in vivo
2. Random shearing by sonication
3. Immunoprecipitation
4. Restriction enzyme digestion
5. Elution & Reverse cross-link
7. Cloning 
6. Fill-in reaction (and/or PCR)
nucleosome target protein antibody
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dissolved in 400 l of the respective restriction enzyme
buVer. After the overnight digestion with gentle rotation at
37 °C, we washed the digested chromatin twice with 500 l
of TE buVer still immobilized to protein A agarose beads.
For the remaining steps, the digested chromatin was treated
the same as in the traditional approach except for skipping
the Wll-in reaction. The reverse cross-linked and Sau3AI-
digested ChIP DNAs were subcloned into the BamHI-
digested pZErO-2 vector. Each ligation mixture was trans-
formed into chemically competent TOP10 cells and subse-
quently plated on LB plates containing 25 g/ml
concentration of Kanamycin.
We assessed the cloning eYciency of the two approaches
by comparing the total clone number and the size distribu-
tion of clone inserts for each library generated from this
study (Fig. 2). The traditional approach generated three
libraries with the total clone numbers ranging from 24 to
80, whereas the modiWed approach generated libraries
ranging from 840 to 2400 clones, which represents at least
one order of magnitude diVerence between the two
approaches using the same amount of starting chromatin
materials. This eliminates one of the main problems in most
ChIP cloning protocols, which is the ineYcient blunt-end
ligation reaction. The median length of clone inserts gener-
ated from the traditional approach was 754 bp, while the
median length by the modiWed approach was 137 bp (Figs.
2A and B). This also demonstrated that restriction enzyme
digestion before the elution step decreases about six fold
the average length of relevant DNA fragments. Our subse-
quent examination of the 196 sequences derived from the
YY1 library further revealed that about 50% of clones have
at least one YY1 binding motif within the sequences of
their inserts (Fig. 2C), which provides a rough estimate on
the feasibility of ChIP cloning approaches for the identiW-
cation of in vivo binding sites for a given transcription fac-
tor. Our strategy using one enzyme, Sau3AI, for chromatin
digestion, however, needs to be improved further in the
future by using diVerent combinations of 4-bp cutters to
avoid the potential cloning bias stemming from uneven dis-
tribution of restriction enzyme sites in genomes. In conclu-
sion, the modiWed protocol greatly increased the number of
clones and shortened further the size of relevant DNA frag-
ments, which should provide higher resolution to study
transcription factor binding sites.
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